Compare WDFC & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WDFC | PBH |
|---|---|---|
| Founded | 1953 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | N/A | 2005 |
| Metric | WDFC | PBH |
|---|---|---|
| Price | $202.48 | $61.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $311.00 | $86.40 |
| AVG Volume (30 Days) | 100.3K | ★ 439.1K |
| Earning Date | 01-08-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 30.92 | N/A |
| EPS | ★ 6.69 | 4.04 |
| Revenue | $619,985,000.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $6.82 | N/A |
| Revenue Next Year | $6.02 | $2.50 |
| P/E Ratio | $30.50 | ★ $15.20 |
| Revenue Growth | ★ 4.98 | N/A |
| 52 Week Low | $186.19 | $57.25 |
| 52 Week High | $273.35 | $90.04 |
| Indicator | WDFC | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 56.45 |
| Support Level | $186.19 | $59.52 |
| Resistance Level | $204.77 | $62.14 |
| Average True Range (ATR) | 4.92 | 1.55 |
| MACD | 0.75 | 0.32 |
| Stochastic Oscillator | 86.92 | 86.90 |
WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.